These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24384233)

  • 21. Induction of tumor cell apoptosis by TRAIL gene therapy.
    Griffith TS
    Methods Mol Biol; 2009; 542():315-34. PubMed ID: 19565910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity.
    Hess C; Neri D
    Cancer Immunol Immunother; 2015 May; 64(5):635-44. PubMed ID: 25722088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early diversification of the TNF superfamily in teleosts: genomic characterization and expression analysis.
    Glenney GW; Wiens GD
    J Immunol; 2007 Jun; 178(12):7955-73. PubMed ID: 17548633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand.
    Duus K; Pagh RT; Holmskov U; Højrup P; Skov S; Houen G
    Scand J Immunol; 2007 Nov; 66(5):501-7. PubMed ID: 17953526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor superfamily ligand mRNA expression profiles differ between humans and mice during homeostasis and between various murine kidney injuries.
    Devarapu SK; Grill JF; Xie J; Weidenbusch M; Honarpisheh M; Vielhauer V; Anders HJ; Mulay SR
    J Biomed Sci; 2017 Sep; 24(1):77. PubMed ID: 28927419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock.
    Tannahill CL; Fukuzuka K; Marum T; Abouhamze Z; MacKay SL; Copeland EM; Moldawer LL
    Surgery; 1999 Aug; 126(2):349-57. PubMed ID: 10455905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
    J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.
    Croft M; Siegel RM
    Nat Rev Rheumatol; 2017 Apr; 13(4):217-233. PubMed ID: 28275260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
    Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
    J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.
    Wyzgol A; Müller N; Fick A; Munkel S; Grigoleit GU; Pfizenmaier K; Wajant H
    J Immunol; 2009 Aug; 183(3):1851-61. PubMed ID: 19596991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.
    Villa A; Lovato V; Bujak E; Wulhfard S; Pasche N; Neri D
    MAbs; 2011; 3(3):264-72. PubMed ID: 21487243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The expression and application of human Fas ligand in E.coli].
    Li NL; Nie H; Yu QW; Bo J; Ma AL; Zhang JY; Shen BH; Wang L; Zhang DQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):20-2. PubMed ID: 15132896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members.
    He Y; van Bommel PE; Samplonius DF; Bremer E; Helfrich W
    Sci Rep; 2017 Oct; 7(1):13301. PubMed ID: 29038485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cell fate by lymphotoxin (LT) receptor signalling: Functional differences and similarities of the LT system to other TNF superfamily (TNFSF) members.
    Albarbar B; Dunnill C; Georgopoulos NT
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):659-71. PubMed ID: 26028499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.